SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jung Ho Park, Hyojin Park, Dong Ho Lee, In Kyung Sung, A Randomized, Double Blinded, Clinical Trial to Assess the Efficacy and Cost Effectiveness of Omeprazole Compared to Rabeprazole in the Maintenance Therapy of Patients With Gastroesophageal Reflux Disease, Journal of Neurogastroenterology and Motility, 2013, 19, 2, 219

    CrossRef

  2. 2
    Sachio Hata, Makoto Arai, Daisuke Maruoka, Takeshi Tanaka, Tomoaki Matsumura, Takuto Suzuki, Tomoo Nakagawa, Tatsuro Katsuno, Fumio Imazeki, Osamu Yokosuka, Intragastric acidity during the first day following administration of low-dose proton pump inhibitors: A randomized crossover study, Clinics and Research in Hepatology and Gastroenterology, 2013, 37, 3, 296

    CrossRef

  3. 3
    Sylvester Chuks Nwokediuko, Current Trends in the Management of Gastroesophageal Reflux Disease: A Review, ISRN Gastroenterology, 2012, 2012, 1

    CrossRef

  4. 4
    Kazuma Fujimoto, Michio Hongo, The Maintenance Study Group, Safety and Efficacy of Long-Term Maintenance Therapy with Oral Dose of Rabeprazole 10 mg Once Daily in Japanese Patients with Reflux Esophagitis, Internal Medicine, 2011, 50, 3, 179

    CrossRef

  5. 5
    M. M. Haber, B. Hunt, J. W. Freston, D. A. Peura, T. O. Kovacs, S. Atkinson, M. Hisada, Changes of gastric histology in patients with erosive oesophagitis receiving long-term lansoprazole maintenance therapy, Alimentary Pharmacology & Therapeutics, 2010, 32, 1
  6. 6
    Henry Cohen, Giselle Tomasso, María Luisa Cafferata, Carlos Zapata, Prateek Sharma, David Armstrong, Joaquim P. Moraes-Filho, Carmelo Blasco, Rodolfo Corti, Gonzalo Estape, Luiz Leite Luna, Rafael Ortuño, Paulo Sakai, Graciela Salis, Daniel Taullard, Esteban Trakal, Miguel Valdovinos, Maria Vergara, Oscar Gónzalez, Latin American Consensus on Gastroesophageal Reflux Disease: An Update on Therapy, Gastroenterología y Hepatología, 2010, 33, 2, 135

    CrossRef

  7. 7
    Akihito Nagahara, Mariko Hojo, Daisuke Asaoka, Sumio Watanabe, Maintenance therapy of gastroesophageal reflux disease, Clinical Journal of Gastroenterology, 2010, 3, 2, 61

    CrossRef

  8. 8
    Kazuma Fujimoto, Michio Hongo, Risk factors for relapse of erosive GERD during long-term maintenance treatment with proton pump inhibitor: a prospective multicenter study in Japan, Journal of Gastroenterology, 2010, 45, 12, 1193

    CrossRef

  9. 9
    Stanislas Bruley des Varannes, Emmanuel Coron, Jean-Paul Galmiche, Short and long-term PPI treatment for GERD. Do we need more-potent anti-secretory drugs?, Best Practice & Research Clinical Gastroenterology, 2010, 24, 6, 905

    CrossRef

  10. 10
    Claudine M. Baldwin, Susan J. Keam, Rabeprazole, Drugs, 2009, 69, 10, 1373

    CrossRef

  11. 11
    J. W. FRESTON, M. HISADA, D. A. PEURA, M. M. HABER, T. O. KOVACS, S. ATKINSON, B. HUNT, The clinical safety of long-term lansoprazole for the maintenance of healed erosive oesophagitis, Alimentary Pharmacology & Therapeutics, 2009, 29, 12
  12. 12
    J. DENT, P. J. KAHRILAS, N. VAKIL, S. VELDHUYZEN VAN ZANTEN, P. BYTZER, B. DELANEY, K. HARUMA, J. HATLEBAKK, E. MCCOLL, P. MOAYYEDI, V. STANGHELLINI, J. TACK, M. VAEZI, Clinical trial design in adult reflux disease: a methodological workshop, Alimentary Pharmacology & Therapeutics, 2008, 28, 1
  13. 13
    Masaki Miyamoto, Ken Haruma, Keisuke Takeuchi, Masao Kuwabara, Frequency scale for symptoms of gastroesophageal reflux disease predicts the need for addition of prokinetics to proton pump inhibitor therapy, Journal of Gastroenterology and Hepatology, 2008, 23, 5
  14. 14
    Stefano Pallotta, Fabio Pace, Silvia Marelli, Rabeprazole: a second-generation proton pump inhibitor in the treatment of acid-related disease, Expert Review of Gastroenterology & Hepatology, 2008, 2, 4, 509

    CrossRef

  15. 15
    M. Frazzoni, M. Manno, E. De Micheli, V. Savarino, Efficacy in intra-oesophageal acid suppression may decrease after 2-year continuous treatment with proton pump inhibitors, Digestive and Liver Disease, 2007, 39, 5, 415

    CrossRef

  16. 16
    Tomohiko Shimatani, Masaki Inoue, Tomoko Kuroiwa, Mutsuko Moriwaki, Jing Xu, Kazuro Ikawa, Norifumi Morikawa, Susumu Tazuma, Which Has Superior Acid-Suppressive Effect, 10 Mg Omeprazole Once Daily or 20 Mg Famotidine Twice Daily? Effects of Single or Repeated Administration in Japanese Helicobacter Pylori-Negative CYP2C19 Extensive Metabolizers, Digestive Diseases and Sciences, 2007, 52, 2, 390

    CrossRef

  17. 17
    Henry Cohen, Joaquim Prado P. Moraes-Filho, Maria Luisa Cafferata, Giselle Tomasso, Graciela Salis, Oscar Gonz??lez, Jorge Valenzuela, Prateek Sharma, Peter Malfertheiner, David Armstrong, Lars Lundell, Rodolfo Corti, Paulo Sakai, Ivan Ceconello, An evidence-based, Latin-American consensus on gastro-oesophageal reflux disease, European Journal of Gastroenterology & Hepatology, 2006, 18, 4, 349

    CrossRef

  18. 18
    Isao Makino, Kimihide Nakamura, Yoichi Sato, Yuzuru Sato, Shuichi Sezai, Yusei Ikeda, Wahei Shinmura, Hajime Watahiki, Hideaki Yamamoto, Yayuki Hioki, Masao Suzuki, Takashi Kumada, Takashi Honda, Tomoo Rikitoku, Yasuhiro Hisanaga, Hiroshi Fukui, Junichi Yamao, Hironaka Kawasaki, Akihide Hosoda, Morikazu Onji, Hidetaka Matsui, Michio Sata, Takuji Torimura, Kazuhiko Oho, Ryuichiro Maekawa, Yoshiyuki Takagi, Satoshi Shakado, Masafumi Nakayama, Kazuhisa Gondo, Hirofumi Fukushima, Taku Kusaba, Hirohito Tsubouchi, Katsuhiro Hayashi, Takeshi Hori, Yozo Iida, Kouki Yutoku, Noboru Maetani, Yoshitsugu Kubo, Yoshifumi Miyata, Postmarketing surveillance of rabeprazole in upper gastrointestinal peptic lesions in Japanese patients with coexisting hepatic disorders, Current Therapeutic Research, 2006, 67, 1, 1

    CrossRef

  19. 19
    Kayoko Oda, Ryuichi Iwakiri, Megumi Hara, Kazuyo Watanabe, Akiko Danjo, Ryo Shimoda, Atsushi Kikkawa, Akifumi Ootani, Hiroyuki Sakata, Seiji Tsunada, Kazuma Fujimoto, Dysphagia Associated with Gastroesophageal Reflux Disease Is Improved by Proton Pump Inhibitor, Digestive Diseases and Sciences, 2005, 50, 10, 1921

    CrossRef

  20. 20
    Guido Rindi, Roberto Fiocca, Anna Morocutti, Adam Jacobs, Neil Miller, Bjarni Thjodleifsson, Effects of 5 years of treatment with rabeprazole or omeprazole on the gastric mucosa, European Journal of Gastroenterology & Hepatology, 2005, 17, 5, 559

    CrossRef

  21. 21
    Lawrence B. Cohen, David A. Johnson, Robert A. Ganz, James Aisenberg, Jacques Devière, T. Raymond Foley, Gregory B. Haber, Jeffrey H. Peters, Glen A. Lehman, Enteryx implantation for GERD: expanded multicenter trial results and interim postapproval follow-up to 24 months, Gastrointestinal Endoscopy, 2005, 61, 6, 650

    CrossRef

  22. 22
    A. CAOS, J. BREITER, C. PERDOMO, J. BARTH, Long-term prevention of erosive or ulcerative gastro-oesophageal reflux disease relapse with rabeprazole 10 or 20 mg vs. placebo: results of a 5-year study in the United States, Alimentary Pharmacology & Therapeutics, 2005, 22, 3
  23. 23
    K.D. Bardhan, A.E. Bishop, J.M. Polak, H.M. Romanska, A. Rowland, M. Thompson, P. Morris, S. Schaefer-Preuss, R. Luehmann, B. McCaldin, Pantoprazole in severe acid-peptic disease: the effectiveness and safety of 5 years’ continuous treatment, Digestive and Liver Disease, 2005, 37, 1, 10

    CrossRef

  24. 24
    Jean-Dominique de Korwin, Philippe Ducrotté, Thierry Vallot, Les nouveaux inhibiteurs de la pompe à protons, un progrès dans la prise en charge des maladies acido-peptiques ?, La Presse Médicale, 2004, 33, 11, 746

    CrossRef

  25. 25
    YOUNG-TAE BAK, Management strategies for gastroesophageal reflux disease, Journal of Gastroenterology and Hepatology, 2004, 19,
  26. 26
    JOSE D SOLLANO, Non-pharmacologic treatment strategies in gastroesophageal reflux disease, Journal of Gastroenterology and Hepatology, 2004, 19,
  27. 27
    Marcello Tonini, Roberto De Giorgio, Fabrizio De Ponti, Progress with Novel Pharmacological Strategies for Gastro-oesophageal Reflux Disease, Drugs, 2004, 64, 4, 347

    CrossRef

  28. 28
    PWY LIM, KL GOH, Review Article: Efficacy and safety of rabeprazole in treating gastroesophageal reflux disease, Journal of Gastroenterology and Hepatology, 2004, 19,
  29. 29
    M. Robinson, Review article: pH, healing and symptom relief with rabeprazole treatment in acid-related disorders, Alimentary Pharmacology & Therapeutics, 2004, 20,
  30. 30
    Bjarni Thjodleifsson, Review of rabeprazole in the treatment of gastro-oesophageal reflux disease, Expert Opinion on Pharmacotherapy, 2004, 5, 1, 137

    CrossRef

  31. 31
    Current awareness: Pharmacoepidemiology and drug safety, Pharmacoepidemiology and Drug Safety, 2003, 12, 6
  32. 32
    Naoki Chiba, M Brian Fennerty, Gastroesophageal Reflux Disease,
  33. 33
    Clare Donnellan, Cathy Preston, Paul Moayyedi, Nav Sharma, Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease, The Cochrane Library,
  34. 34
    Clare Donnellan, Cathy Preston, Paul Moayyedi, Nav Sharma, Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease, The Cochrane Library,
  35. 35
    Mark Tighe, Nadeem A Afzal, Amanda Bevan, Andrew Hayen, Alasdair Munro, R Mark Beattie, Pharmacological treatment of children with gastro-oesophageal reflux, The Cochrane Library,